2019

June 5

Specific Diagnostics Invited to Present at Rapid AST Symposium at IDWeek

Specific Diagnostics has been invited to present its Reveal Rapid AST system at a symposium entitled “Rapid Diagnostics and Resistance: Making Sense of Now and the Future Part 1 – Rapid Phenotypic AST Methods” at IDWeek October 4, in Washington, DC. “Specific welcomes this opportunity to share information about the Reveal instrument which by this time will be in clinical trials in Europe,” said Paul A. Rhodes, Ph.D., Specific Diagnostics CEO.  “We are pleased that the symposium committee extended this invitation.”

March 29

Specific Diagnostics begins clinical demonstrations and testing of the Reveal AST system

Specific Diagnostics today announced clinical demonstrations of the Reveal AST system will be conducted at a clinical laboratory in Amsterdam during the ECCMID conference April 13-16.  The Reveal AST™ system delivers phenotypic AST in an average of 4 hours, directly from positive blood culture or isolate dilutions.  The system provides minimum inhibitory concentration (MIC) with wide antimicrobial coverage for bacteria species responsible for bloodstream and other acute infections. 

March 28

Specific Diagnostics achieves CARB-X milestone and advances its Reveal™ rapid antibiotic susceptibility test for life-threatening drug-resistant infections towards clinical testing

Specific Diagnostics announced today that, based on the achievement of development and testing milestones, CARB-X has proceeded with a second stage of funding for Specific’s Revealrapid antibiotic susceptibility test (AST) instrument.  Specific will receive up to $1.7 million, which is on top of the $1.7 million already awarded by CARB-X. The additional $1.7M will enable Specific’s preparation for clinical trials in 2019 of this important new diagnostic system.  The original CARB-X award, announced April 4, 2018, helped support development of the Reveal AST system, which offers the same-day susceptibility results needed to change the way drug-resistant infections are diagnosed and treated.